Strides Pharma to conduct trials in India for potential COVID-19 drug

The Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call, without giving any more details.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Tkn9zN
via IFTTT